Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

Share Price is delayed by 15 minutes
Get Live Data
282.30    2.90 (1.04%)
Bid:
282.20
Ask:
282.40
Spread: 0.20 (0.071%)
Market Cap: £4.73b
KGF Live PriceLast checked at - London Stock Exchange

Intraday Kingfisher Share Chart

Share Repurchase Programme - Fifth Tranche

17 Jan 2025 07:30

RNS Number : 7506T
Kingfisher PLC
17 January 2025
 

 

KINGFISHER PLCShare Repurchase Programme - Fifth and Final Tranche

17 January 2025: Kingfisher plc (the "Company" or "Kingfisher") announces that it has instructed Goldman Sachs International ("GSI") in relation to a non-discretionary programme to purchase its shares for cancellation, during the period which will commence today and end no later than 24 March 2025 (the "Tranche"). GSI will act as principal for the on-sale of such shares to the Company, and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company.

The maximum amount allocated to the Tranche (excluding expenses) will be no greater than £75 million (Note 1). The purpose of the Tranche is to reduce the share capital of the Company. As such, the Company will cancel any ordinary shares purchased. This is the fifth and final tranche of an overall commitment by the Company to purchase £300 million of its shares for cancellation, as announced on 19 September 2023 (the "Programme"). To date, the Company has repurchased and cancelled 85,315,628 shares under the Programme.

Any acquisitions under the Programme will be carried out within certain pre-set parameters, and in accordance with the Company's general authority to repurchase shares, the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 9 of the Listing Rules. The Company confirms that it currently has no unpublished price sensitive information.

For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.

Note 1. The maximum number of shares that the Company may purchase would be 144,799,115 ordinary shares of 15 5/7 pence each, in line with the authority granted to Kingfisher by shareholders at the Company's Annual General Meeting on 20 June 2024 and taking into account the 18,612,440 shares and 23,977,312 shares purchased and cancelled during the third and fourth tranches of the Programme, respectively.

 

 

Contacts

Tel:

Email:

Company Secretary

+44 (0) 77 6880 6248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Treasury

+44 (0) 20 7372 8008

treasury@kingfisher.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGRGDBLBBDGUR
Date   Source Headline
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 202510:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 202511:00 amRNS2025 AGM Update Statement
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20251:00 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20253:30 pmRNSHolding(s) in Company
28th Nov 20257:30 amRNSShare Repurchase Programme - Fourth Tranche
25th Nov 20257:00 amRNSQ3 Trading Update
18th Nov 202510:00 amRNSDirector/PDMR Shareholding
17th Nov 20253:00 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNS-RRetail Investor Presentation
17th Nov 20257:05 amRNSThird Tranche of Share Repurchase Programme
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20252:30 pmRNSBlock listing Interim Review
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20251:30 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 202511:00 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20254:30 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20253:30 pmRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20253:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.